Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Devices & Consumables > Antimicrobial Resistance Surveillance- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Antimicrobial Resistance Surveillance- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 134 Pages

Report ld: 3901151

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Antimicrobial Resistance Surveillance was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Antimicrobial resistance (AMR) surveillance involves monitoring and analyzing the resistance of microorganisms, particularly bacteria, to antibiotics and other antimicrobial drugs.

North American market for Antimicrobial Resistance Surveillance was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antimicrobial Resistance Surveillance was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Antimicrobial Resistance Surveillance was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Antimicrobial Resistance Surveillance include BD, Biomerieux, Thermo Fisher Scientific, Danaher, Luminex, Bruker, Merck KgaA, Bio-Rad, Qiagen, Abbott Laboratories, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Antimicrobial Resistance Surveillance, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antimicrobial Resistance Surveillance by region & country, by Type, and by Application.

The Antimicrobial Resistance Surveillance market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Resistance Surveillance.

Market Segmentation

Report Metric
Details
Report Title
Antimicrobial Resistance Surveillance- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Market Size Available for Years
2025-2031
Global Antimicrobial Resistance Surveillance Companies Covered
BD
Biomerieux
Thermo Fisher Scientific
Danaher
Luminex
Bruker
Merck KgaA
Bio-Rad
Qiagen
Abbott Laboratories
Roche Diagnostics
OpGen
Wolters Kluwer
Lumed
BioSpace
Cepheid
Accelerate Diagnostics
Liofilchem
Alifax S.r.l.
Bioanalyse
Global Antimicrobial Resistance Surveillance Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antimicrobial Resistance Surveillance Market, Segment by Type
Diagnostic Kit
Diagnostic System
Surveillance Software
Global Antimicrobial Resistance Surveillance Market, Segment by Application
Hospitals
Research institute
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antimicrobial Resistance Surveillance manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antimicrobial Resistance Surveillance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antimicrobial Resistance Surveillance in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Antimicrobial Resistance Surveillance Product Introduction
    1.2 Global Antimicrobial Resistance Surveillance Market Size Forecast
        1.2.1 Global Antimicrobial Resistance Surveillance Sales Value (2020-2031)
        1.2.2 Global Antimicrobial Resistance Surveillance Sales Volume (2020-2031)
        1.2.3 Global Antimicrobial Resistance Surveillance Sales Price (2020-2031)
    1.3 Antimicrobial Resistance Surveillance Market Trends & Drivers
        1.3.1 Antimicrobial Resistance Surveillance Industry Trends
        1.3.2 Antimicrobial Resistance Surveillance Market Drivers & Opportunity
        1.3.3 Antimicrobial Resistance Surveillance Market Challenges
        1.3.4 Antimicrobial Resistance Surveillance Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Antimicrobial Resistance Surveillance Players Revenue Ranking (2024)
    2.2 Global Antimicrobial Resistance Surveillance Revenue by Company (2020-2025)
    2.3 Global Antimicrobial Resistance Surveillance Players Sales Volume Ranking (2024)
    2.4 Global Antimicrobial Resistance Surveillance Sales Volume by Company Players (2020-2025)
    2.5 Global Antimicrobial Resistance Surveillance Average Price by Company (2020-2025)
    2.6 Key Manufacturers Antimicrobial Resistance Surveillance Manufacturing Base and Headquarters
    2.7 Key Manufacturers Antimicrobial Resistance Surveillance Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Antimicrobial Resistance Surveillance
    2.9 Antimicrobial Resistance Surveillance Market Competitive Analysis
        2.9.1 Antimicrobial Resistance Surveillance Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Antimicrobial Resistance Surveillance Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Resistance Surveillance as of 2024)
    2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Diagnostic Kit
        3.1.2 Diagnostic System
        3.1.3 Surveillance Software
    3.2 Global Antimicrobial Resistance Surveillance Sales Value by Type
        3.2.1 Global Antimicrobial Resistance Surveillance Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Antimicrobial Resistance Surveillance Sales Value, by Type (2020-2031)
        3.2.3 Global Antimicrobial Resistance Surveillance Sales Value, by Type (%) (2020-2031)
    3.3 Global Antimicrobial Resistance Surveillance Sales Volume by Type
        3.3.1 Global Antimicrobial Resistance Surveillance Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Antimicrobial Resistance Surveillance Sales Volume, by Type (2020-2031)
        3.3.3 Global Antimicrobial Resistance Surveillance Sales Volume, by Type (%) (2020-2031)
    3.4 Global Antimicrobial Resistance Surveillance Average Price by Type (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Research institute
        4.1.3 Others
    4.2 Global Antimicrobial Resistance Surveillance Sales Value by Application
        4.2.1 Global Antimicrobial Resistance Surveillance Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Antimicrobial Resistance Surveillance Sales Value, by Application (2020-2031)
        4.2.3 Global Antimicrobial Resistance Surveillance Sales Value, by Application (%) (2020-2031)
    4.3 Global Antimicrobial Resistance Surveillance Sales Volume by Application
        4.3.1 Global Antimicrobial Resistance Surveillance Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Antimicrobial Resistance Surveillance Sales Volume, by Application (2020-2031)
        4.3.3 Global Antimicrobial Resistance Surveillance Sales Volume, by Application (%) (2020-2031)
    4.4 Global Antimicrobial Resistance Surveillance Average Price by Application (2020-2031)

5 Segmentation by Region
    5.1 Global Antimicrobial Resistance Surveillance Sales Value by Region
        5.1.1 Global Antimicrobial Resistance Surveillance Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Antimicrobial Resistance Surveillance Sales Value by Region (2020-2025)
        5.1.3 Global Antimicrobial Resistance Surveillance Sales Value by Region (2026-2031)
        5.1.4 Global Antimicrobial Resistance Surveillance Sales Value by Region (%), (2020-2031)
    5.2 Global Antimicrobial Resistance Surveillance Sales Volume by Region
        5.2.1 Global Antimicrobial Resistance Surveillance Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Antimicrobial Resistance Surveillance Sales Volume by Region (2020-2025)
        5.2.3 Global Antimicrobial Resistance Surveillance Sales Volume by Region (2026-2031)
        5.2.4 Global Antimicrobial Resistance Surveillance Sales Volume by Region (%), (2020-2031)
    5.3 Global Antimicrobial Resistance Surveillance Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        5.4.2 North America Antimicrobial Resistance Surveillance Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        5.5.2 Europe Antimicrobial Resistance Surveillance Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        5.6.2 Asia Pacific Antimicrobial Resistance Surveillance Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        5.7.2 South America Antimicrobial Resistance Surveillance Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        5.8.2 Middle East & Africa Antimicrobial Resistance Surveillance Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Antimicrobial Resistance Surveillance Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Antimicrobial Resistance Surveillance Sales Value
        6.2.1 Key Countries/Regions Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Antimicrobial Resistance Surveillance Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        6.3.2 United States Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Antimicrobial Resistance Surveillance Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        6.4.2 Europe Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Antimicrobial Resistance Surveillance Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        6.5.2 China Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Antimicrobial Resistance Surveillance Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        6.6.2 Japan Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Antimicrobial Resistance Surveillance Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        6.7.2 South Korea Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Antimicrobial Resistance Surveillance Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        6.8.2 Southeast Asia Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Antimicrobial Resistance Surveillance Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Antimicrobial Resistance Surveillance Sales Value, 2020-2031
        6.9.2 India Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Antimicrobial Resistance Surveillance Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 BD
        7.1.1 BD Company Information
        7.1.2 BD Introduction and Business Overview
        7.1.3 BD Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 BD Antimicrobial Resistance Surveillance Product Offerings
        7.1.5 BD Recent Development
    7.2 Biomerieux
        7.2.1 Biomerieux Company Information
        7.2.2 Biomerieux Introduction and Business Overview
        7.2.3 Biomerieux Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Biomerieux Antimicrobial Resistance Surveillance Product Offerings
        7.2.5 Biomerieux Recent Development
    7.3 Thermo Fisher Scientific
        7.3.1 Thermo Fisher Scientific Company Information
        7.3.2 Thermo Fisher Scientific Introduction and Business Overview
        7.3.3 Thermo Fisher Scientific Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Thermo Fisher Scientific Antimicrobial Resistance Surveillance Product Offerings
        7.3.5 Thermo Fisher Scientific Recent Development
    7.4 Danaher
        7.4.1 Danaher Company Information
        7.4.2 Danaher Introduction and Business Overview
        7.4.3 Danaher Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Danaher Antimicrobial Resistance Surveillance Product Offerings
        7.4.5 Danaher Recent Development
    7.5 Luminex
        7.5.1 Luminex Company Information
        7.5.2 Luminex Introduction and Business Overview
        7.5.3 Luminex Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Luminex Antimicrobial Resistance Surveillance Product Offerings
        7.5.5 Luminex Recent Development
    7.6 Bruker
        7.6.1 Bruker Company Information
        7.6.2 Bruker Introduction and Business Overview
        7.6.3 Bruker Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 Bruker Antimicrobial Resistance Surveillance Product Offerings
        7.6.5 Bruker Recent Development
    7.7 Merck KgaA
        7.7.1 Merck KgaA Company Information
        7.7.2 Merck KgaA Introduction and Business Overview
        7.7.3 Merck KgaA Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Merck KgaA Antimicrobial Resistance Surveillance Product Offerings
        7.7.5 Merck KgaA Recent Development
    7.8 Bio-Rad
        7.8.1 Bio-Rad Company Information
        7.8.2 Bio-Rad Introduction and Business Overview
        7.8.3 Bio-Rad Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.8.4 Bio-Rad Antimicrobial Resistance Surveillance Product Offerings
        7.8.5 Bio-Rad Recent Development
    7.9 Qiagen
        7.9.1 Qiagen Company Information
        7.9.2 Qiagen Introduction and Business Overview
        7.9.3 Qiagen Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.9.4 Qiagen Antimicrobial Resistance Surveillance Product Offerings
        7.9.5 Qiagen Recent Development
    7.10 Abbott Laboratories
        7.10.1 Abbott Laboratories Company Information
        7.10.2 Abbott Laboratories Introduction and Business Overview
        7.10.3 Abbott Laboratories Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.10.4 Abbott Laboratories Antimicrobial Resistance Surveillance Product Offerings
        7.10.5 Abbott Laboratories Recent Development
    7.11 Roche Diagnostics
        7.11.1 Roche Diagnostics Company Information
        7.11.2 Roche Diagnostics Introduction and Business Overview
        7.11.3 Roche Diagnostics Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.11.4 Roche Diagnostics Antimicrobial Resistance Surveillance Product Offerings
        7.11.5 Roche Diagnostics Recent Development
    7.12 OpGen
        7.12.1 OpGen Company Information
        7.12.2 OpGen Introduction and Business Overview
        7.12.3 OpGen Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.12.4 OpGen Antimicrobial Resistance Surveillance Product Offerings
        7.12.5 OpGen Recent Development
    7.13 Wolters Kluwer
        7.13.1 Wolters Kluwer Company Information
        7.13.2 Wolters Kluwer Introduction and Business Overview
        7.13.3 Wolters Kluwer Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.13.4 Wolters Kluwer Antimicrobial Resistance Surveillance Product Offerings
        7.13.5 Wolters Kluwer Recent Development
    7.14 Lumed
        7.14.1 Lumed Company Information
        7.14.2 Lumed Introduction and Business Overview
        7.14.3 Lumed Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.14.4 Lumed Antimicrobial Resistance Surveillance Product Offerings
        7.14.5 Lumed Recent Development
    7.15 BioSpace
        7.15.1 BioSpace Company Information
        7.15.2 BioSpace Introduction and Business Overview
        7.15.3 BioSpace Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.15.4 BioSpace Antimicrobial Resistance Surveillance Product Offerings
        7.15.5 BioSpace Recent Development
    7.16 Cepheid
        7.16.1 Cepheid Company Information
        7.16.2 Cepheid Introduction and Business Overview
        7.16.3 Cepheid Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.16.4 Cepheid Antimicrobial Resistance Surveillance Product Offerings
        7.16.5 Cepheid Recent Development
    7.17 Accelerate Diagnostics
        7.17.1 Accelerate Diagnostics Company Information
        7.17.2 Accelerate Diagnostics Introduction and Business Overview
        7.17.3 Accelerate Diagnostics Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.17.4 Accelerate Diagnostics Antimicrobial Resistance Surveillance Product Offerings
        7.17.5 Accelerate Diagnostics Recent Development
    7.18 Liofilchem
        7.18.1 Liofilchem Company Information
        7.18.2 Liofilchem Introduction and Business Overview
        7.18.3 Liofilchem Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.18.4 Liofilchem Antimicrobial Resistance Surveillance Product Offerings
        7.18.5 Liofilchem Recent Development
    7.19 Alifax S.r.l.
        7.19.1 Alifax S.r.l. Company Information
        7.19.2 Alifax S.r.l. Introduction and Business Overview
        7.19.3 Alifax S.r.l. Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.19.4 Alifax S.r.l. Antimicrobial Resistance Surveillance Product Offerings
        7.19.5 Alifax S.r.l. Recent Development
    7.20 Bioanalyse
        7.20.1 Bioanalyse Company Information
        7.20.2 Bioanalyse Introduction and Business Overview
        7.20.3 Bioanalyse Antimicrobial Resistance Surveillance Sales, Revenue, Price and Gross Margin (2020-2025)
        7.20.4 Bioanalyse Antimicrobial Resistance Surveillance Product Offerings
        7.20.5 Bioanalyse Recent Development

8 Industry Chain Analysis
    8.1 Antimicrobial Resistance Surveillance Industrial Chain
    8.2 Antimicrobial Resistance Surveillance Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Antimicrobial Resistance Surveillance Sales Model
        8.5.2 Sales Channel
        8.5.3 Antimicrobial Resistance Surveillance Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Antimicrobial Resistance Surveillance Market Trends
 Table 2. Antimicrobial Resistance Surveillance Market Drivers & Opportunity
 Table 3. Antimicrobial Resistance Surveillance Market Challenges
 Table 4. Antimicrobial Resistance Surveillance Market Restraints
 Table 5. Global Antimicrobial Resistance Surveillance Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Antimicrobial Resistance Surveillance Revenue Market Share by Company (2020-2025)
 Table 7. Global Antimicrobial Resistance Surveillance Sales Volume by Company (2020-2025) & (K Units)
 Table 8. Global Antimicrobial Resistance Surveillance Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Antimicrobial Resistance Surveillance Price by Company (2020-2025) & (US$/Unit)
 Table 10. Key Manufacturers Antimicrobial Resistance Surveillance Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Antimicrobial Resistance Surveillance Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Antimicrobial Resistance Surveillance
 Table 13. Global Antimicrobial Resistance Surveillance Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Resistance Surveillance as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antimicrobial Resistance Surveillance Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Antimicrobial Resistance Surveillance Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Antimicrobial Resistance Surveillance Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Antimicrobial Resistance Surveillance Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Antimicrobial Resistance Surveillance Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Antimicrobial Resistance Surveillance Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global Antimicrobial Resistance Surveillance Sales Volume by Type (2020-2025) & (K Units)
 Table 23. Global Antimicrobial Resistance Surveillance Sales Volume by Type (2026-2031) & (K Units)
 Table 24. Global Antimicrobial Resistance Surveillance Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Antimicrobial Resistance Surveillance Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Antimicrobial Resistance Surveillance Price by Type (2020-2025) & (US$/Unit)
 Table 27. Global Antimicrobial Resistance Surveillance Price by Type (2026-2031) & (US$/Unit)
 Table 28. Global Antimicrobial Resistance Surveillance Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Antimicrobial Resistance Surveillance Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Antimicrobial Resistance Surveillance Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Antimicrobial Resistance Surveillance Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Antimicrobial Resistance Surveillance Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Antimicrobial Resistance Surveillance Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
 Table 34. Global Antimicrobial Resistance Surveillance Sales Volume by Application (2020-2025) & (K Units)
 Table 35. Global Antimicrobial Resistance Surveillance Sales Volume by Application (2026-2031) & (K Units)
 Table 36. Global Antimicrobial Resistance Surveillance Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Antimicrobial Resistance Surveillance Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Antimicrobial Resistance Surveillance Price by Application (2020-2025) & (US$/Unit)
 Table 39. Global Antimicrobial Resistance Surveillance Price by Application (2026-2031) & (US$/Unit)
 Table 40. Global Antimicrobial Resistance Surveillance Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Antimicrobial Resistance Surveillance Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Antimicrobial Resistance Surveillance Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Antimicrobial Resistance Surveillance Sales Value by Region (2020-2025) & (%)
 Table 44. Global Antimicrobial Resistance Surveillance Sales Value by Region (2026-2031) & (%)
 Table 45. Global Antimicrobial Resistance Surveillance Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
 Table 46. Global Antimicrobial Resistance Surveillance Sales Volume by Region (2020-2025) & (K Units)
 Table 47. Global Antimicrobial Resistance Surveillance Sales Volume by Region (2026-2031) & (K Units)
 Table 48. Global Antimicrobial Resistance Surveillance Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Antimicrobial Resistance Surveillance Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Antimicrobial Resistance Surveillance Average Price by Region (2020-2025) & (US$/Unit)
 Table 51. Global Antimicrobial Resistance Surveillance Average Price by Region (2026-2031) & (US$/Unit)
 Table 52. Key Countries/Regions Antimicrobial Resistance Surveillance Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Antimicrobial Resistance Surveillance Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Antimicrobial Resistance Surveillance Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Antimicrobial Resistance Surveillance Sales Volume, (2020-2025) & (K Units)
 Table 56. Key Countries/Regions Antimicrobial Resistance Surveillance Sales Volume, (2026-2031) & (K Units)
 Table 57. BD Company Information
 Table 58. BD Introduction and Business Overview
 Table 59. BD Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 60. BD Antimicrobial Resistance Surveillance Product Offerings
 Table 61. BD Recent Development
 Table 62. Biomerieux Company Information
 Table 63. Biomerieux Introduction and Business Overview
 Table 64. Biomerieux Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 65. Biomerieux Antimicrobial Resistance Surveillance Product Offerings
 Table 66. Biomerieux Recent Development
 Table 67. Thermo Fisher Scientific Company Information
 Table 68. Thermo Fisher Scientific Introduction and Business Overview
 Table 69. Thermo Fisher Scientific Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 70. Thermo Fisher Scientific Antimicrobial Resistance Surveillance Product Offerings
 Table 71. Thermo Fisher Scientific Recent Development
 Table 72. Danaher Company Information
 Table 73. Danaher Introduction and Business Overview
 Table 74. Danaher Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Danaher Antimicrobial Resistance Surveillance Product Offerings
 Table 76. Danaher Recent Development
 Table 77. Luminex Company Information
 Table 78. Luminex Introduction and Business Overview
 Table 79. Luminex Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Luminex Antimicrobial Resistance Surveillance Product Offerings
 Table 81. Luminex Recent Development
 Table 82. Bruker Company Information
 Table 83. Bruker Introduction and Business Overview
 Table 84. Bruker Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Bruker Antimicrobial Resistance Surveillance Product Offerings
 Table 86. Bruker Recent Development
 Table 87. Merck KgaA Company Information
 Table 88. Merck KgaA Introduction and Business Overview
 Table 89. Merck KgaA Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Merck KgaA Antimicrobial Resistance Surveillance Product Offerings
 Table 91. Merck KgaA Recent Development
 Table 92. Bio-Rad Company Information
 Table 93. Bio-Rad Introduction and Business Overview
 Table 94. Bio-Rad Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Bio-Rad Antimicrobial Resistance Surveillance Product Offerings
 Table 96. Bio-Rad Recent Development
 Table 97. Qiagen Company Information
 Table 98. Qiagen Introduction and Business Overview
 Table 99. Qiagen Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Qiagen Antimicrobial Resistance Surveillance Product Offerings
 Table 101. Qiagen Recent Development
 Table 102. Abbott Laboratories Company Information
 Table 103. Abbott Laboratories Introduction and Business Overview
 Table 104. Abbott Laboratories Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Abbott Laboratories Antimicrobial Resistance Surveillance Product Offerings
 Table 106. Abbott Laboratories Recent Development
 Table 107. Roche Diagnostics Company Information
 Table 108. Roche Diagnostics Introduction and Business Overview
 Table 109. Roche Diagnostics Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 110. Roche Diagnostics Antimicrobial Resistance Surveillance Product Offerings
 Table 111. Roche Diagnostics Recent Development
 Table 112. OpGen Company Information
 Table 113. OpGen Introduction and Business Overview
 Table 114. OpGen Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 115. OpGen Antimicrobial Resistance Surveillance Product Offerings
 Table 116. OpGen Recent Development
 Table 117. Wolters Kluwer Company Information
 Table 118. Wolters Kluwer Introduction and Business Overview
 Table 119. Wolters Kluwer Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 120. Wolters Kluwer Antimicrobial Resistance Surveillance Product Offerings
 Table 121. Wolters Kluwer Recent Development
 Table 122. Lumed Company Information
 Table 123. Lumed Introduction and Business Overview
 Table 124. Lumed Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 125. Lumed Antimicrobial Resistance Surveillance Product Offerings
 Table 126. Lumed Recent Development
 Table 127. BioSpace Company Information
 Table 128. BioSpace Introduction and Business Overview
 Table 129. BioSpace Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 130. BioSpace Antimicrobial Resistance Surveillance Product Offerings
 Table 131. BioSpace Recent Development
 Table 132. Cepheid Company Information
 Table 133. Cepheid Introduction and Business Overview
 Table 134. Cepheid Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 135. Cepheid Antimicrobial Resistance Surveillance Product Offerings
 Table 136. Cepheid Recent Development
 Table 137. Accelerate Diagnostics Company Information
 Table 138. Accelerate Diagnostics Introduction and Business Overview
 Table 139. Accelerate Diagnostics Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 140. Accelerate Diagnostics Antimicrobial Resistance Surveillance Product Offerings
 Table 141. Accelerate Diagnostics Recent Development
 Table 142. Liofilchem Company Information
 Table 143. Liofilchem Introduction and Business Overview
 Table 144. Liofilchem Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 145. Liofilchem Antimicrobial Resistance Surveillance Product Offerings
 Table 146. Liofilchem Recent Development
 Table 147. Alifax S.r.l. Company Information
 Table 148. Alifax S.r.l. Introduction and Business Overview
 Table 149. Alifax S.r.l. Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 150. Alifax S.r.l. Antimicrobial Resistance Surveillance Product Offerings
 Table 151. Alifax S.r.l. Recent Development
 Table 152. Bioanalyse Company Information
 Table 153. Bioanalyse Introduction and Business Overview
 Table 154. Bioanalyse Antimicrobial Resistance Surveillance Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 155. Bioanalyse Antimicrobial Resistance Surveillance Product Offerings
 Table 156. Bioanalyse Recent Development
 Table 157. Key Raw Materials Lists
 Table 158. Raw Materials Key Suppliers Lists
 Table 159. Antimicrobial Resistance Surveillance Downstream Customers
 Table 160. Antimicrobial Resistance Surveillance Distributors List
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources


List of Figures
 Figure 1. Antimicrobial Resistance Surveillance Product Picture
 Figure 2. Global Antimicrobial Resistance Surveillance Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Antimicrobial Resistance Surveillance Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Antimicrobial Resistance Surveillance Sales Volume (2020-2031) & (K Units)
 Figure 5. Global Antimicrobial Resistance Surveillance Sales Price (2020-2031) & (US$/Unit)
 Figure 6. Antimicrobial Resistance Surveillance Report Years Considered
 Figure 7. Global Antimicrobial Resistance Surveillance Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Antimicrobial Resistance Surveillance Players Sales Volume Ranking (2024) & (K Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antimicrobial Resistance Surveillance Revenue in 2024
 Figure 10. Antimicrobial Resistance Surveillance Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Diagnostic Kit Picture
 Figure 12. Diagnostic System Picture
 Figure 13. Surveillance Software Picture
 Figure 14. Global Antimicrobial Resistance Surveillance Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 15. Global Antimicrobial Resistance Surveillance Sales Value Market Share by Type, 2024 & 2031
 Figure 16. Global Antimicrobial Resistance Surveillance Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
 Figure 17. Global Antimicrobial Resistance Surveillance Sales Volume Market Share by Type, 2024 & 2031
 Figure 18. Global Antimicrobial Resistance Surveillance Price by Type (2020-2031) & (US$/Unit)
 Figure 19. Product Picture of Hospitals
 Figure 20. Product Picture of Research institute
 Figure 21. Product Picture of Others
 Figure 22. Global Antimicrobial Resistance Surveillance Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 23. Global Antimicrobial Resistance Surveillance Sales Value Market Share by Application, 2024 & 2031
 Figure 24. Global Antimicrobial Resistance Surveillance Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
 Figure 25. Global Antimicrobial Resistance Surveillance Sales Volume Market Share by Application, 2024 & 2031
 Figure 26. Global Antimicrobial Resistance Surveillance Price by Application (2020-2031) & (US$/Unit)
 Figure 27. North America Antimicrobial Resistance Surveillance Sales Value (2020-2031) & (US$ Million)
 Figure 28. North America Antimicrobial Resistance Surveillance Sales Value by Country (%), 2024 VS 2031
 Figure 29. Europe Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 30. Europe Antimicrobial Resistance Surveillance Sales Value by Country (%), 2024 VS 2031
 Figure 31. Asia Pacific Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Antimicrobial Resistance Surveillance Sales Value by Region (%), 2024 VS 2031
 Figure 33. South America Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 34. South America Antimicrobial Resistance Surveillance Sales Value by Country (%), 2024 VS 2031
 Figure 35. Middle East & Africa Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 36. Middle East & Africa Antimicrobial Resistance Surveillance Sales Value by Country (%), 2024 VS 2031
 Figure 37. Key Countries/Regions Antimicrobial Resistance Surveillance Sales Value (%), (2020-2031)
 Figure 38. Key Countries/Regions Antimicrobial Resistance Surveillance Sales Volume (%), (2020-2031)
 Figure 39. United States Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 40. United States Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
 Figure 41. United States Antimicrobial Resistance Surveillance Sales Value by Application (%), 2024 VS 2031
 Figure 42. Europe Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 43. Europe Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
 Figure 44. Europe Antimicrobial Resistance Surveillance Sales Value by Application (%), 2024 VS 2031
 Figure 45. China Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 46. China Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
 Figure 47. China Antimicrobial Resistance Surveillance Sales Value by Application (%), 2024 VS 2031
 Figure 48. Japan Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 49. Japan Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
 Figure 50. Japan Antimicrobial Resistance Surveillance Sales Value by Application (%), 2024 VS 2031
 Figure 51. South Korea Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 52. South Korea Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
 Figure 53. South Korea Antimicrobial Resistance Surveillance Sales Value by Application (%), 2024 VS 2031
 Figure 54. Southeast Asia Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 55. Southeast Asia Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
 Figure 56. Southeast Asia Antimicrobial Resistance Surveillance Sales Value by Application (%), 2024 VS 2031
 Figure 57. India Antimicrobial Resistance Surveillance Sales Value, (2020-2031) & (US$ Million)
 Figure 58. India Antimicrobial Resistance Surveillance Sales Value by Type (%), 2024 VS 2031
 Figure 59. India Antimicrobial Resistance Surveillance Sales Value by Application (%), 2024 VS 2031
 Figure 60. Antimicrobial Resistance Surveillance Industrial Chain
 Figure 61. Antimicrobial Resistance Surveillance Manufacturing Cost Structure
 Figure 62. Channels of Distribution (Direct Sales, and Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed

Description

The global market for Antimicrobial Resistance Surveillance was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Antimicrobial resistance (AMR) surveillance involves monitoring and analyzing the resistance of microorganisms, particularly bacteria, to antibiotics and other antimicrobial drugs.

North American market for Antimicrobial Resistance Surveillance was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antimicrobial Resistance Surveillance was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Antimicrobial Resistance Surveillance was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Antimicrobial Resistance Surveillance include BD, Biomerieux, Thermo Fisher Scientific, Danaher, Luminex, Bruker, Merck KgaA, Bio-Rad, Qiagen, Abbott Laboratories, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Antimicrobial Resistance Surveillance, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antimicrobial Resistance Surveillance by region & country, by Type, and by Application.

The Antimicrobial Resistance Surveillance market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Resistance Surveillance.

Market Segmentation

Related Reports

Global Antimicrobial Resistance Surveillance Market Research Report 2024
Antimicrobial resistance (AMR) surveillance involves monitoring and analyzing the resistance of microorganisms, particularly bacteria, to antibiotics and other antimicrobial drugs.
Published: 2024-01-17
Pages: 115
USD 2900.00
(Single User License)
Global Antimicrobial Resistance Surveillance Market Research Report 2025
The global market for Antimicrobial Resistance Surveillance was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 107
USD 2900.00
(Single User License)
Global Antimicrobial Resistance Surveillance Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antimicrobial Resistance Surveillance market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 106
USD 4250.00
(Single User License)
Global Antimicrobial Resistance Surveillance Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Antimicrobial Resistance Surveillance market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 171
USD 4900.00
(Single User License)
Global Antimicrobial Resistance Surveillance Market Research Report 2026
The global Antimicrobial Resistance Surveillance market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 133
USD 2900.00
(Single User License)
Antimicrobial Resistance Surveillance- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antimicrobial Resistance Surveillance was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 147
USD 3950.00
(Single User License)

Global Antimicrobial Resistance Surveillance Market Research Report 2024
Antimicrobial resistance (AMR) surveillance involves monitoring and analyzing the resistance of microorganisms, particularly bacteria, to antibiotics and other antimicrobial drugs.
Published: 2024-01-17
Pages: 115
USD 2900.00 ()
Global Antimicrobial Resistance Surveillance Market Research Report 2025
The global market for Antimicrobial Resistance Surveillance was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 107
USD 2900.00 ()
Global Antimicrobial Resistance Surveillance Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antimicrobial Resistance Surveillance market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 106
USD 4250.00 ()
Global Antimicrobial Resistance Surveillance Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Antimicrobial Resistance Surveillance market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 171
USD 4900.00 ()
Global Antimicrobial Resistance Surveillance Market Research Report 2026
The global Antimicrobial Resistance Surveillance market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 133
USD 2900.00 ()
Antimicrobial Resistance Surveillance- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antimicrobial Resistance Surveillance was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 147
USD 3950.00 ()